Rationale: Whether selective serotonin reuptake inhibitors (SSRIs) exposure during adolescent brain development\r\ncauses lasting effects remains unresolved.\r\nObjective: Assess the effects of fluoxetine and paroxetine 60 days after adolescent exposure compared with when\r\non-drug.\r\nMethods: Male Sprague-Dawley littermates (41 litters) were gavaged on postnatal days 33-53 with fluoxetine (3 or\r\n10 mg/kg/day), paroxetine (3, 10 or, 17 mg/kg/day), or water; half were tested while on-drug (21 litters) and half\r\nafter 60 days off-drug (20 litters).\r\nResults: The highest dose of the drugs reduced body weight gain during treatment that rebounded 1 week posttreatment.\r\nOn-drug, no significant group differences were found on elevated plus maze time-in-open, zone entries,\r\nor latency to first open entry; however, the high dose of paroxetine significantly reduced head-dips (N = 20/\r\ngroup). No significant effects were found on-drug for acoustic startle response/prepulse inhibition (ASR/PPI)\r\nalthough a trend (p < 0.10) was seen, which after combining dose levels, showed a significant increase in ASR\r\namplitude for both fluoxetine and paroxetine (N = 20-21/group). No differences on immobility time were seen in\r\nthe Porsolt forced swim test or in plasma corticosterone at the end of forced swim (N-19-21/group). Off-drug, no\r\neffects were seen in the elevated plus maze (N = 16/group), ASR/PPI (N = 20/group), forced swim (N = 19-20/\r\ngroup), or plasma corticosterone (N = 19/group). At the doses tested, fluoxetine and paroxetine induced minor\r\neffects with drug on-board but no residual, long-term adverse effects in rats 60 days after drug discontinuation.\r\nConclusions: The data provide no evidence that fluoxetine or paroxetine have long-term adverse effects on the\r\nbehaviors measured here after adolescent to young adult exposure.
Loading....